241 related articles for article (PubMed ID: 33098033)
1. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Jeong J; Kim SW; Sung DH
J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
[TBL] [Abstract][Full Text] [Related]
3.
Tan X; Sun X; Yuan H; He L; Ding C; Jiang L
Hell J Nucl Med; 2022; 25(3):285-296. PubMed ID: 36507885
[TBL] [Abstract][Full Text] [Related]
4. The role of 18F-FDG PET/CT in Neurolymphomatosis: A Comprehensive Imaging Approach.
Usmani S; Jain A; Riyami KA; Ahmed N; Al-Sukaiti R; Shamim MS
J Pak Med Assoc; 2024 Apr; 74(4):822-824. PubMed ID: 38751291
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
[TBL] [Abstract][Full Text] [Related]
6. B-cell peripheral neurolymphomatosis: MRI and
DeVries AH; Howe BM; Spinner RJ; Broski SM
Skeletal Radiol; 2019 Jul; 48(7):1043-1050. PubMed ID: 30666391
[TBL] [Abstract][Full Text] [Related]
7. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
8. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
[TBL] [Abstract][Full Text] [Related]
9. Neurolymphomatosis in follicular lymphoma: an autopsy case report.
Ando T; Kamoshita S; Riku Y; Ito A; Ozawa Y; Miyamura K; Fujino M; Ito M; Goto Y; Mano K; Akagi A; Miyahara H; Katsuno M; Yoshida M; Iwasaki Y
Neuropathology; 2022 Aug; 42(4):295-301. PubMed ID: 35607714
[TBL] [Abstract][Full Text] [Related]
10. Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes.
Kamiya-Matsuoka C; Shroff S; Gildersleeve K; Hormozdi B; Manning JT; Woodman KH
J Neurol Sci; 2014 Aug; 343(1-2):144-8. PubMed ID: 24928074
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy.
Suga K; Yasuhiko K; Matsunaga N; Yujiri T; Nakazora T; Ariyoshi K
Clin Nucl Med; 2011 Jan; 36(1):73-6. PubMed ID: 21157220
[TBL] [Abstract][Full Text] [Related]
12. [A case of neurolymphomatosis].
Gelezhe PB; Medvedeva AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):150-153. PubMed ID: 36036417
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience.
Byun JM; Kim KH; Kim M; Kim TM; Jeon YK; Park JH; Paik JH; Lee JM; Lee HY; Lee JS; Heo DS; Lee JO
Leuk Lymphoma; 2017 Nov; 58(11):2624-2632. PubMed ID: 28482727
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases.
Canh NX; Tan NV; Tung TT; Son NT; Maurea S
Asia Ocean J Nucl Med Biol; 2014; 2(1):57-64. PubMed ID: 27408859
[TBL] [Abstract][Full Text] [Related]
15. Secondary neurolymphomatosis of spinal nerve roots detected by ¹⁸F-FDG PET/CT: a case report and differential diagnosis of the case.
Wang Y; Wang J; Jiang C; Peng Q; Wu M; Ma X
Hell J Nucl Med; 2015; 18(3):261-3. PubMed ID: 26574697
[TBL] [Abstract][Full Text] [Related]
16. Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report.
Hong CM; Lee SW; Lee HJ; Song BI; Kim HW; Kang S; Jeong SY; Ahn BC; Lee J; Chae YS
Nucl Med Mol Imaging; 2011 Mar; 45(1):76-8. PubMed ID: 24899982
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Imaging Analysis of FDG PET/CT Imaging for Detection of Central Neurolymphomatosis in a Case of Recurrent Diffuse B-Cell Lymphoma.
Shaikh F; Savells D; Awan O; Inayat F; Chaudhry A; Jerath N; Graham MM
Cureus; 2015 Nov; 7(11):e379. PubMed ID: 26719822
[TBL] [Abstract][Full Text] [Related]
18. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma.
Shaikh F; Chan AC; Awan O; Jerath N; Reddy C; Khan SA; Graham MM
Cureus; 2015 Sep; 7(9):e319. PubMed ID: 26487995
[TBL] [Abstract][Full Text] [Related]
20. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S
Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]